SEC Form 4 · accession 0001450324-15-000002
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas K. Equels
Officer — CFO, Vice Chairman, Secretary · Director
Period of report
Apr 20, 2015
Accepted (ET)
Apr 21, 2015 · 10:00 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 20, 2015 | P | 100,000 | $0.2391 | A | 1,205,444 | D |
Table II — derivative securities
No Table II lines on this filing.